Research

Researches

Research News

27 May 2015

An international symposium on Microbes & brain at Institut Pasteur, Paris on July 3, 2015 - Registration are open

This symposium will take place at the Institut Pasteur within the framework of the Grand Programme Fédérateur Microbes & Brain (GPF M&B), which aims at creating synergy between Neurosciences, Microbiology and Immunology, three strong research traditions at the Institut. This synergy should generate cutting-edge knowledge of how microbes and brain interact to maintain health or drive pathology.

The objective is to present ground-breaking research deciphering the impact of microbiota on biological functions related to the nervous system, including the blood brain barrier, metabolism and immunity of the brain, and behavior.

 
Organizers from the Institut Pasteur, Paris
- Gérard Eberl
- Ivo Gomperts Boneca
- Monique Lafon
- Pierre Legrain
- Pierre-Marie Lledo
- Uwe Maskos

Speakers
Sebastien BOHLER, Pour la Science, France
John CRYAN, University College Cork, Ireland
Jane FOSTER, The Brain-Body Institute, Canada
Lloyd KASPER, Dartmouth Medical School, United States
Wolfgang KUNZE, The Brain-Body Institute, Canada
Marion LEBOYER, Groupe Hospitalier Chenevier-Mondor, France
Pierre-Marie LLEDO, Institut Pasteur, France 
Sarkis MAZMANIAN, Caltech, United States
Michal SCHWARTZ, Weizmann Institute of Science, Israel
 
Registration 
You can register for the conference through the secure site
 

14 May 2015

International Meeting on Respiratory Pathogens in Singapore from 2-4 September 2015 - Deadline to submit abstract: 25 May

The International Meeting on Respiratory Pathogens (IMRP) is hosting by the International Society of Influenza and Respiratory Viruses (ISIRV). It aims to bring together more than 400 international participants (clinicians, public health professionals, scientists, and policy makers) to discuss respiratory viruses, bacteria, and other pathogens.

The Institut Pasteur and the Institut Pasteur International Network (IPIN) are part of the meeting’s contributors. Malik Peiris, director of HKU-Pasteur Research Pole and Jean-Michel Heraud, Head of the Virology Lab at Institut Pasteur of Madagascar and board member of ISIRV, will be part of the invited speakers. This meeting will enable to share recent advances in epidemiology, immunology, diagnostics, vaccines and therapeutics and clinical management.  A provisional program of the meeting is already available on the IMRP website (see URL)

Abstract submission deadline 25th May 2015

Guidelines for abstract submission can be found here.

(IMRP-website) http://www.isirv.org/site/index.php/component/content/article/9-events/234-1st-international-meeting-on-respiratory-pathogens

(IPIN-flyer) http://www.pasteur.fr/sites/www.pasteur.fr/files/plaquette_riip_september2014.pdf

(IPIN-website) http://www.pasteur.fr/en/international/institut-pasteur-international-network

07 May 2015

Institut Pasteur joins major stakeholders of Infectious Diseases in calling for the creation of “A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance”

The position paper, to be published in PLoS Med has been signed by Christian Brechot, President of the Institut Pasteur and other leaders of international organizations engaged in global health, including Medecins Sans Frontieres, the Wellcome Trust, DNDi with Bernard Pecoul, the Peking University and the Harvard T.H Chan School of Public Health, highlights the deficit in innovation of new tools in relation to the identified needs to face up to all the global health concerns.

The authors have highlighted anti-microbial resistance, emerging infectious diseases, and neglected diseases as the most serious health challenges.

In line with WHO suggestions, the paper calls for alternative models to fund and incentivize R&D, supported by a global normative R&D framework that would deliver both innovation and access.

 

The events of 2014 with the devastating Ebola outbreak have shown that crisis management is more risky and costly, and less effective,than a prepared health system. This holds true for the innovation needs, and demonstratesthe need for a preparedness R&D mechanism that can quickly deliver innovativeresponses to emerging health threats.

 

This assay raises the fact that serious changes has to be done like stimulating innovation and ensuring access to health technologies for those who need them to avoid the past issues. This topic must be a key priority at the G7 summit in June 2015.